Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Compounds and pharmaceutical compositions for inhibiting MRP1

Compounds and pharmaceutical compositions for inhibiting MRP1

US Patent 7101891 · Granted Sep 5, 2006

Estimated economic value: $72,797,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Selective estrogen receptor degraders2024
Selective estrogen receptor degraders2024
Selective estrogen receptor degraders2023
Selective estrogen receptor degraders2021
1-tetrahydropyranylcarbonyl-2,3-dihydro-1H-indole compounds for treating cancer2020
Selective estrogen receptor degraders2020
2,3-dihydro-1H-indole compounds2018
1-oxo-1,2-dihydroisoquinolin-7-yl-(5-substituted-thiophen-2-yl)-sulfonamide comp2017
Compounds, methods and formulations for the oral delivery of a glucagon-like pep2014
Compounds, methods and formulations for the oral delivery of a glucagon-like pep2014
Compounds, methods and formulations for the oral delivery of a glucagon-like pep2013
Compounds, methods and formulations for the oral delivery of a glucagon-like pep2013